Clinical and Translational Medicine最新文献

筛选
英文 中文
Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis-associated encephalopathy TIPE2通过抑制小胶质细胞热凋亡和糖酵解在败血症相关脑病治疗中的调节作用。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-06 DOI: 10.1002/ctm2.70881
Min Yuan, Yunzhao Yang, Huifan Liu, Qian Kong, Guoqing Jing, Hailong Gong, Yuxuan Wang, Zhengyu Zhang, Wanhong Liu, Xuemin Song, Zhongyuan Xia, Xiaojing Wu
{"title":"Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis-associated encephalopathy","authors":"Min Yuan,&nbsp;Yunzhao Yang,&nbsp;Huifan Liu,&nbsp;Qian Kong,&nbsp;Guoqing Jing,&nbsp;Hailong Gong,&nbsp;Yuxuan Wang,&nbsp;Zhengyu Zhang,&nbsp;Wanhong Liu,&nbsp;Xuemin Song,&nbsp;Zhongyuan Xia,&nbsp;Xiaojing Wu","doi":"10.1002/ctm2.70881","DOIUrl":"10.1002/ctm2.70881","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Sepsis_associated encephalopathy (SAE) denotes acute cerebral dysfunction triggered by sepsis and is accompanied by high mortality. Our previous study showed that TIPE2 significantly ameliorated cognitive impairment in SAE mice by inhibiting neuroinflammation, but the specific mechanism was unknown.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>TIPE2 expression and cell specificity were analysed by scRNA‑seq and immunofluorescence. To establish SAE, cecal ligation and puncture (CLP) was carried out in TIPE2 knockout (KO) and WT mice. Neuronal/synaptic damage was assessed by TUNEL and TEM; cognitive function by behavioural tests and EEG. Hippocampal scRNA‑seq compared WT and TIPE2 KO mice. In vitro, primary microglia and BV2 cells were stimulated with LPS/nigericin. Protein expression (Western blot/IF), RhoA activation (GST‑pulldown), glucose/lactate levels, ROS production, and TIPE2‑RhoA interaction (Co‑IP/confocal) were examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>scRNA‑seq confirmed that TIPE2 is predominantly expressed in microglia and downregulated in SAE; its deficiency promotes pro‑inflammatory microglia associated with pyroptosis and glycolysis. TIPE2 KO significantly aggravated cognitive impairment, promoted M1 polarisation, enhanced pyroptosis (GSDMD cleavage, caspase‑1 activation), and increased ROS production. Mechanistically, TIPE2 directly bound to RhoA and inhibited its activation, thereby suppressing NLRP3‑mediated pyroptosis and glycolysis in microglia. Treatment with the RhoA‑specific inhibitor Rhosin reversed TIPE2 deficiency‑induced microglial polarisation, pyroptosis, ROS production, and glycolytic reprogramming, and also ameliorated cognitive dysfunction in TIPE2 KO mice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>TIPE2 protects against SAE by directly interacting with RhoA, inhibiting its activation, and subsequently suppressing NLRP3‑mediated microglial pyroptosis and glycolysis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70881","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circular RNA SMAD4 coordinates with m6A-dependent IGF2BP2 to promote gallbladder cancer development 环状RNA SMAD4与m6a依赖性IGF2BP2协同促进胆囊癌的发展。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-05 DOI: 10.1002/ctm2.70892
Yiming Li, Yayun Xu, Yuan Zhang, Si Gao, Lili Gao, Zhiqing Yuan, Ziyi Wang, Shimei Qiu, Peipei Xu, Yuanding Liu, Zhaonan Liu, Huijie Miao, Hang Xu, Maolan Li, Rong Shao, Yingbin Liu
{"title":"Circular RNA SMAD4 coordinates with m6A-dependent IGF2BP2 to promote gallbladder cancer development","authors":"Yiming Li,&nbsp;Yayun Xu,&nbsp;Yuan Zhang,&nbsp;Si Gao,&nbsp;Lili Gao,&nbsp;Zhiqing Yuan,&nbsp;Ziyi Wang,&nbsp;Shimei Qiu,&nbsp;Peipei Xu,&nbsp;Yuanding Liu,&nbsp;Zhaonan Liu,&nbsp;Huijie Miao,&nbsp;Hang Xu,&nbsp;Maolan Li,&nbsp;Rong Shao,&nbsp;Yingbin Liu","doi":"10.1002/ctm2.70892","DOIUrl":"10.1002/ctm2.70892","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Circular RNAs (circRNAs) have emerged as important regulators in tumorigenesis through microRNA sponging, protein translation and interaction with RNA-binding proteins. Here, we identified a novel circRNA termed circSMAD4 that was generated by alternative splicing from exon 2 to exon 10 and back to the beginning of exon 2 of SMAD4 pre-mRNA, constituting a 1435-nucleotide circular RNA. circSMAD4 was upregulated in gallbladder cancer (GBC) tissues and positively correlated with cancer progression. Elevated expression and tumorigenic activity of circSMAD4 mainly relied on its interaction with IGF2BP2, where m<sup>6</sup>A-binding motifs located at KH3 and KH4 of IGF2BP2 recognized and bound to the flanking intron sequences of circSMAD4. In the cytoplasm, IGF2BP2 stabilized circSMAD4 levels, and circSMAD4 in turn inhibited ubiquitination and degradation of IGF2BP2, thereby creating a positive feedback loop for both elevated expressions. Collaboration of circSMAD4 and IGF2BP2 activated JAK2/STAT3 and epithelial–mesenchymal transition (EMT) signalling. Notably, treatment of xenografted mouse models with CWI1-2, a small molecule for interruption of IGF2BP2 binding to circRNA, resulted in decreases in circSMAD4-induced tumour development. Collectively, our findings suggest that circSMAD4 cooperates with IGF2BP2 to promote tumour progression, highlighting the circSMAD4-IGF2BP2 complex as a potential therapeutic target in GBC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70892","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FSP1 as the convergent hub of autophagy and ubiquitination governing ferroptosis in monocrotaline-induced pulmonary arterial hypertension FSP1作为自噬和泛素化的聚合中心,调控单芥碱诱导的肺动脉高压中的铁凋亡。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-05 DOI: 10.1002/ctm2.70822
Dandan Chen, Qi Jin, Lei Zhang, Wenzhi Pan, Daxin Zhou, Junbo Ge, Lihua Guan
{"title":"FSP1 as the convergent hub of autophagy and ubiquitination governing ferroptosis in monocrotaline-induced pulmonary arterial hypertension","authors":"Dandan Chen,&nbsp;Qi Jin,&nbsp;Lei Zhang,&nbsp;Wenzhi Pan,&nbsp;Daxin Zhou,&nbsp;Junbo Ge,&nbsp;Lihua Guan","doi":"10.1002/ctm2.70822","DOIUrl":"10.1002/ctm2.70822","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The interaction mechanism between autophagy and ferroptosis in pulmonary arterial hypertension (PAH) remains unclear. We identified FSP1 as a core molecular node linking these two critical processes. Mechanistically, the degradation of FSP1 is coordinately regulated by NBR1-mediated autophagic flux and RNFT1-driven K63-linked ubiquitination, collectively exacerbating ferroptosis and PAH progression. Combination therapy involving FSP1 overexpression and the autophagy inhibitor Apelin-13 synergistically alleviates PAH in rats by stabilizing FSP1 and suppressing ferroptosis. This study not only reveals a dual-pathway mechanism regulating FSP1 stability and validates a novel therapeutic strategy targeting FSP1 degradation but also provides a novel combined intervention strategy for the clinical treatment of PAH.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Background and objective</h3>\u0000 \u0000 <p>The interaction between autophagy and ferroptosis in pulmonary arterial hypertension (PAH) remains poorly understood. This study aims to elucidate the role of ferroptosis suppressor protein 1 (FSP1) as a central molecular node linking these processes and to explore a combined therapeutic strategy targeting FSP1 degradation for PAH intervention.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Molecular biology techniques were employed to analyse FSP1 degradation pathways, focusing on NBR1-mediated autophagic flux and RNFT1-driven K63-linked ubiquitination. A rat PAH model was established to evaluate the therapeutic efficacy of combining FSP1 overexpression with the autophagy inhibitor Apelin-13.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>FSP1 stability was coordinately regulated by autophagy and ubiquitination: NBR1 promoted autophagic degradation of FSP1, while RNFT1 exacerbated this process via K63-linked ubiquitination, collectively accelerating ferroptosis and PAH progression. The combination of FSP1 overexpression and Apelin-13 synergistically stabilized FSP1, suppressed ferroptosis, and alleviated PAH symptoms in rats.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study reveals a dual-pathway mechanism governing FSP1 stability through autophagy-ubiquitination crosstalk, highlighting its critical role in ferroptosis-driven PAH. The combination therapy targeting FSP1 degradation presents a novel strategic approach for clinical PAH treatment.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70822","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic alterations in stool microbiota composition following faecal transplantation in patients with inflammatory bowel disease 炎症性肠病患者粪便移植后粪便微生物群组成的动态变化
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-05 DOI: 10.1002/ctm2.70888
Evgenii I. Olekhnovich, Tatyana N. Kalachnyuk, Elena S. Zhgun, Artem B. Ivanov, Dmitry E. Fedorov, Ksenia M. Klimina, Vladimir A. Veselovsky, Daria I. Boldyreva, Andrey K. Larin, Roman I. Matorin, Svetlana V. Lyamina, Dmitriy N. Andreev, Igor V. Maev, Irina Balazs, Vadim M. Govorun, Alexander V. Pavlenko, Julia A. Bespyatykh, Elena N. Ilina
{"title":"Dynamic alterations in stool microbiota composition following faecal transplantation in patients with inflammatory bowel disease","authors":"Evgenii I. Olekhnovich,&nbsp;Tatyana N. Kalachnyuk,&nbsp;Elena S. Zhgun,&nbsp;Artem B. Ivanov,&nbsp;Dmitry E. Fedorov,&nbsp;Ksenia M. Klimina,&nbsp;Vladimir A. Veselovsky,&nbsp;Daria I. Boldyreva,&nbsp;Andrey K. Larin,&nbsp;Roman I. Matorin,&nbsp;Svetlana V. Lyamina,&nbsp;Dmitriy N. Andreev,&nbsp;Igor V. Maev,&nbsp;Irina Balazs,&nbsp;Vadim M. Govorun,&nbsp;Alexander V. Pavlenko,&nbsp;Julia A. Bespyatykh,&nbsp;Elena N. Ilina","doi":"10.1002/ctm2.70888","DOIUrl":"10.1002/ctm2.70888","url":null,"abstract":"&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;Faecal microbiota transplantation (FMT) is being investigated for its impact on gut microbiota in various diseases, including inflammatory bowel disease (IBD). Further data are needed on FMT effectiveness across IBD subtypes and optimal therapeutic regimens. New analytical methods can improve understanding of IBD pathogenesis and FMT effects, and facilitate standardised guidelines for donor screening, FMT prescription, and success evaluation. In this exploratory single-arm longitudinal study, FMT effects on gut microbiota in IBD patients were investigated over one month. Compositional and trajectory analyses quantified microbiome restructuring and shifts towards donor and healthy profiles, accounting for concurrent reduction in disease activity. Donor-derived colonisation was assessed, and taxonomic and functional changes were characterised using differential ranking and pathway enrichment. Given the small sample size (&lt;i&gt;n&lt;/i&gt; = 14), the study was not powered for confirmatory between-group comparisons; between-group results are exploratory.&lt;/p&gt;&lt;p&gt;Fourteen patients (eight Crohn's disease [CD] and six ulcerative colitis [UC]) with active disease (HBI 5.4 ± 0.8; SCCAI 6.7 ± 0.8) were enrolled and underwent endoscopic FMT (100 mL donor faecal suspension into the jejunum) alongside standard anti-inflammatory therapy (Table 1 and Figure 1; Supporting Information File S1). Stool samples were collected before FMT and at 2, 7, 14 and 30 days after FMT and underwent shotgun metagenomic sequencing (Supporting Information File S2). Six healthy donors screened according to the previously published algorithm&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; provided faecal material. Taxonomic and functional profiles were generated for the study cohort (Supporting Information Files S3 and S4), and an external reference cohort was used for taxonomic comparison (Supporting Information File S5).&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; Multivariate analysis comprised non-metric MDS based on Aitchison distance, PERMANOVA, and multiple regression on distance matrices (MRM), while robust Aitchison PCA (RPCA) was performed on merged data with an external reference cohort; Axis 1 served as a quantitative phenotype for trajectory comparison. Differential rankings and log ratios were complemented by gene set enrichment analysis, and donor-derived microbes were detected in post-FMT recipient metagenomes (Supporting Information File S6).&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; Longitudinal analyses used mixed and generalised linear modelling, with post-hoc power analysis.&lt;/p&gt;&lt;p&gt;Within-subject effects were first assessed using PERMANOVA with patient stratification, which confirmed that both clinical index and time point significantly structured microbial composition (&lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; = 0.046, &lt;i&gt;p&lt;/i&gt; = 0.018; &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; = 0.039, &lt;i&gt;p&lt;/i&gt; = 0.002, respectively), indicating progressive within-subject restructuring over the follow-up period. Between-subject effects were then tested using MRM, w","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70888","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zdhhc14 promotes pyroptosis in the dorsal root ganglion of oxaliplatin-induced peripheral neuropathy mice by enhancing GBP5 palmitoylation and suppressing its ubiquitination Zdhhc14通过增强GBP5棕榈酰化和抑制其泛素化,促进奥沙利铂诱导的周围神经病变小鼠背根神经节焦亡。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-04 DOI: 10.1002/ctm2.70874
Xiao Jiang, Wanqiu Li, Yanzhuo Liu, Wei Song, Xuedan Zheng, Liu Tang
{"title":"Zdhhc14 promotes pyroptosis in the dorsal root ganglion of oxaliplatin-induced peripheral neuropathy mice by enhancing GBP5 palmitoylation and suppressing its ubiquitination","authors":"Xiao Jiang,&nbsp;Wanqiu Li,&nbsp;Yanzhuo Liu,&nbsp;Wei Song,&nbsp;Xuedan Zheng,&nbsp;Liu Tang","doi":"10.1002/ctm2.70874","DOIUrl":"10.1002/ctm2.70874","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Oxaliplatin-related neuropathy (OIPN) remains a frequent chemotherapy-induced complication, yet its underlying mechanisms remain incompletely understood. Emerging evidence implicates pyroptosis in OIPN pathogenesis, and palmitoylation has been recognised as a critical mechanism in neurological disorders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This investigation set out to examine the part played by the palmitoyltransferase Zdhhc14 in pyroptosis in OIPN as well as to clarify the fundamental molecular processes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A mouse model of OIPN was developed through intraperitoneal oxaliplatin administration, and primary neuronal cultures derived from dorsal root ganglia were exposed to oxaliplatin to simulate OIPN in vitro. Bioinformatics analysis was performed using the GSE255097 dataset. Gene and protein expression were examined by quantitative real-time PCR, Western blot and immunofluorescence staining. Pyroptosis was assessed by lactate dehydrogenase release, flow cytometry and detection of pyroptosis-related proteins. Co-immunoprecipitation, immunoprecipitation and cycloheximide chase assay were applied to evaluate the mechanisms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Zdhhc14 was significantly up-regulated in dorsal root ganglion (DRG) of OIPN mice in a time-dependent manner. Zdhhc14 deficiency alleviated OIPN phenotypes, including mechanical hyperalgesia and cold allodynia, neuroinflammation and DRG pyroptosis. Mechanistically, Zdhhc14 binds to GBP5 and promotes its modification at Cys12, which is required for Zdhhc14-mediated suppression of K48-linked ubiquitination and subsequent proteasomal degradation, thereby stabilising GBP5. GBP5 knockdown phenocopied the protective effects of Zdhhc14 deficiency, whereas GBP5 overexpression reversed these effects. Importantly, mutation of the GBP5 palmitoylation site abolished the pro-pyroptotic effects of Zdhhc14.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These findings indicate that the Zdhhc14/GBP5 palmitoylation axis critically regulates DRG pyroptosis and neuroinflammation in OIPN, identifying a novel mechanism and a potential mechanistic target warranting further translational evaluation for this debilitating condition.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13733372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis 铁转运蛋白缺乏通过cGAS-STING-STAT3生存轴驱动卵巢癌的奥拉帕尼耐药
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-02 DOI: 10.1002/ctm2.70885
Jiagui Song, Zhengyang Guo, Decao Yang, Ping Yu, Yinjia Li, Zhuhui Yuan, Xiaojuan Ma, Xianlong Li, Hongyan Guo, Lixiang Xue, Tong Liu
{"title":"Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis","authors":"Jiagui Song,&nbsp;Zhengyang Guo,&nbsp;Decao Yang,&nbsp;Ping Yu,&nbsp;Yinjia Li,&nbsp;Zhuhui Yuan,&nbsp;Xiaojuan Ma,&nbsp;Xianlong Li,&nbsp;Hongyan Guo,&nbsp;Lixiang Xue,&nbsp;Tong Liu","doi":"10.1002/ctm2.70885","DOIUrl":"https://doi.org/10.1002/ctm2.70885","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Ovarian cancer (OC) remains the most lethal gynaecological malignancy, and acquired resistance to PARP inhibitors such as olaparib represents a major clinical challenge. Although dysregulation of iron metabolism has been implicated in tumorigenesis, the specific role of the iron exporter &lt;i&gt;SLC40A1&lt;/i&gt; (ferroportin, FPN) in mediating olaparib resistance remains poorly understood. The study aimed to elucidate the clinical significance of FPN deficiency and to explore therapeutic strategies for reversing olaparib resistance.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;FPN expression was evaluated in OC samples from a clinical cohort of 19 patients, stratified by olaparib responsiveness, to determine its prognostic value. Functional mechanisms were investigated using multiple OC cell lines, patient-derived organoids (PDOs), and mouse xenograft models. We integrated analyses of iron homeostasis, ROS dynamics, DNA repair capacity, and innate immune signaling, with a focus on the cGAS–STING–STAT3 signaling cascade. The therapeutic potential of combining olaparib with the ferroptosis inducer erastin or the STING inhibitor C-176 was assessed as a strategy to overcome FPN deficiency-driven resistance.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Clinically, FPN expression was significantly downregulated in olaparib-resistant tissues compared with sensitive controls (&lt;i&gt;p&lt;/i&gt; &lt; 0.05), and low FPN levels were strongly associated with poor therapeutic outcomes. Mechanistically, FPN deficiency promoted intracellular iron accumulation and ROS generation, which led to increased ferroptosis vulnerability, impaired homologous recombination repair (HRR) and concomitant activation of the cGAS–STING–STAT3 inflammatory axis, thereby driving olaparib resistance. Notably, in vivo studies demonstrated that combining olaparib with either erastin or C-176 significantly suppressed tumour growth and restored drug sensitivity compared with monotherapy (&lt;i&gt;p&lt;/i&gt; &lt; 0.01), supporting the translational potential of targeting this axis.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Our study establishes a clinically relevant mechanistic connection between ferroportin deficiency and cGAS–STING–STAT3-mediated olaparib resistance in OC. We identify the FPN–ROS–cGAS–STING–STAT3 axis as an actionable vulnerability in resistant OC, indicating that this pathway is a promising therapeutic target to overcome olaparib resistance.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Highlights","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70885","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149311271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The microbiome and brain metastasis in non-small cell lung cancer: A graded appraisal and a framework for prevention-oriented research 非小细胞肺癌的微生物组和脑转移:分级评价和预防导向研究框架
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-01 DOI: 10.1002/ctm2.70862
Long Liang, Fangjuan Hu, Xiaofeng Wang, Chunhan Tang, Chun Wang, Gefei Jiang, Chungang Zhao, Yin Zhang, Churong Li
{"title":"The microbiome and brain metastasis in non-small cell lung cancer: A graded appraisal and a framework for prevention-oriented research","authors":"Long Liang,&nbsp;Fangjuan Hu,&nbsp;Xiaofeng Wang,&nbsp;Chunhan Tang,&nbsp;Chun Wang,&nbsp;Gefei Jiang,&nbsp;Chungang Zhao,&nbsp;Yin Zhang,&nbsp;Churong Li","doi":"10.1002/ctm2.70862","DOIUrl":"https://doi.org/10.1002/ctm2.70862","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Brain metastasis remains a major cause of mortality and treatment failure in non-small cell lung cancer (NSCLC). However, current models of cerebral dissemination rarely integrate microbiome-dependent systemic and intratumoral biology.This Review examines the potential microbiome-brain metastasis axis linking gut, lung, and intratumoral microbial communities to intracranial dissemination and therapeutic response.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A reproducible literature search was conducted to evaluate proposed mechanisms underlying microbiome-associated brain metastasis. Evidence for each mechanistic claim was graded using a four-level evidence scheme (E1-E4), while microbial detection confidence was assessed using a four-tier hierarchy (D1-D4).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;No component of the proposed axis reached E1 evidence, and all published microbial observations in NSCLC brain metastasis rests on nucleic-acid detection alone. Five mechanisms are examined: circulating microbial metabolites acting on endothelial permeability and glial reactivity; microbiome-imprinted immune-cell trafficking;intracellular bacteria within primary lung tumours; cross-kingdom MR1/MAIT and Dectin-CARD9 signalling; and candidate host genetic determinants. The available human data are small, single-centre and cross-sectional, reporting association with brain-metastasis status rather than prediction or causation; that bacteria accompany disseminating tumour cells into the brain remains a hypothesis awaiting paired sampling, spatial localization and experimental perturbation.We therefore reserve the term prevention for proposed trials, integrate microbial features with established molecular risk models, and specify the genetic-perturbation program and research-only decision pathway that would convert these claims into E1 evidence.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The microbiome–brain metastasis axis provides a hypothesis-generating framework for investigating microbial contributions to cerebral dissemination. Multi-centre validation, paired primary-brain metastasis profiling and gnotobiotic models are required before microbiome-directed strategies can be said to improve intracranial outcomes;until then this framework is hypothesis-generating, not practice-changing.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Key points&lt;/h3&gt;\u0000 \u0000 &lt;div&gt;\u0000 &lt;ul&gt;\u0000 \u0000 &lt;","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70862","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149310813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation-induced lung injury. HDAC3通过MKP1去乙酰化在辐射诱导的肺损伤中驱动II型肺泡上皮屏障功能障碍。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-01 DOI: 10.1002/ctm2.70877
Boyang Li, Ning Li, Rui Xiong, Yifan Zuo, Yi Liu, Guoqing Luo, Wenjun Zhang, Zhuya Xiao, Long Wu, Min Peng
{"title":"HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation-induced lung injury.","authors":"Boyang Li, Ning Li, Rui Xiong, Yifan Zuo, Yi Liu, Guoqing Luo, Wenjun Zhang, Zhuya Xiao, Long Wu, Min Peng","doi":"10.1002/ctm2.70877","DOIUrl":"10.1002/ctm2.70877","url":null,"abstract":"<p><p>Histone deacetylase 3 (HDAC3) is a key biological macromolecule involved in protein acetylation and inflammatory signalling. Although its biological functions are well recognised, the molecular mechanisms through which HDAC3 regulates stress-induced responses of alveolar epithelial cells during early-stage radiation-induced lung injury (RILI) remain incompletely understood. In this study, using AT2-specific HDAC3 conditional knockout mice as well as primary mouse AT2 and A549 cell models, we found that radiation markedly upregulates HDAC3 expression, whereas HDAC3 knockdown alleviates radiation-induced disruption of the alveolar epithelial barrier. Transcriptomic analysis further revealed that HDAC3 influences barrier integrity by modulating MAPK-mediated inflammation and apoptosis. Pharmacological intervention with the selective HDAC3 inhibitor RGFP966 also demonstrated that HDAC3 inhibition mitigates radiation-induced oxidative stress imbalance. Mechanistically, HDAC3 deacetylates MKP1, enhancing p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation, promoting FBJ murine osteosarcoma viral oncogene homolog (c-Fos) expression, and activating activator protein-1 (AP-1), thereby driving downstream inflammatory signalling. Collectively, our findings support a role for the HDAC3-MKP1-p38 MAPK-c-Fos/AP-1 axis in regulating inflammatory responses in AT2 cells and highlight HDAC3 as a potential molecular target for mitigating alveolar epithelial injury in early-stage RILI.</p>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serpina3n deficiency exacerbates sepsis-induced myocardial dysfunction by disrupting fibroblast-cardiomyocyte crosstalk. Serpina3n缺乏通过破坏成纤维细胞-心肌细胞串扰加剧败血症诱导的心肌功能障碍。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-01 DOI: 10.1002/ctm2.70898
Xunuo Wang, Yufeng Yan, Aiqing Kong, Xiya Li, Hao Xie, Zuoying Hu, Guangfeng Zuo
{"title":"Serpina3n deficiency exacerbates sepsis-induced myocardial dysfunction by disrupting fibroblast-cardiomyocyte crosstalk.","authors":"Xunuo Wang, Yufeng Yan, Aiqing Kong, Xiya Li, Hao Xie, Zuoying Hu, Guangfeng Zuo","doi":"10.1002/ctm2.70898","DOIUrl":"https://doi.org/10.1002/ctm2.70898","url":null,"abstract":"<p><strong>Background: </strong>Sepsis-induced myocardial dysfunction (SIMD) is a key contributor to death among individuals with sepsis. Serpina3n (a serine protease inhibitor) contributes critically to various cardiovascular diseases. However, whether Serpina3n is involved in SIMD and its underlying mechanisms remain unclear.</p><p><strong>Methods: </strong>A SIMD model was established by either an intraperitoneal injection of lipopolysaccharide (LPS) or caecal ligation and puncture (CLP) in mice. Single-cell RNA sequencing (scRNA-seq) was carried out to examine Serpina3n expression and its cellular localisation in mouse hearts. Serpina3n expression was also examined in LPS-treated neonatal mouse cardiac fibroblasts (NMCFs) and neonatal mouse cardiomyocytes (NMCMs). Global Serpina3n knockout (KO) (Serpina3n<sup>-/-</sup>) and fibroblast-specific Serpina3n-deficient (Serpina3n<sup>flox/flox</sup>, Col1a2-iCre) mouse models were used for functional validation in vivo.</p><p><strong>Results: </strong>Serpina3n expression was notably up-regulated in the hearts of SIMD mice, and it was enriched mainly in cardiac fibroblasts (CFs). Consistent with the scRNA-seq data, Serpina3n expression was markedly increased in LPS-treated NMCFs but not in NMCMs. Furthermore, both global Serpina3n KO and fibroblast-specific Serpina3n deletion exacerbated cardiac inflammation and dysfunction, facilitated the progression of SIMD and ultimately increased mortality. Mechanistically, LPS stimulation promoted the secretion of Serpina3n from CFs, which acted on cardiomyocytes (CMs) in a paracrine manner, thereby attenuating the expression of proteins related to the Janus kinase/signal transducer and activator of transcription signalling pathway and reducing cardiac inflammatory cell infiltration to ultimately exert a cardioprotective effect. These processes were disrupted by fibroblast-specific Serpina3n deficiency.</p><p><strong>Conclusions: </strong>Collectively, these findings indicate that CF-derived Serpina3n mediates CF-CM crosstalk and plays an essential protective role in SIMD, providing mechanistic insights and a potential candidate target for further preclinical investigations of SIMD.</p>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A wearable perspiration biosensor for continuous biomarker monitoring in inflammatory bowel disease: Feasibility, concordance, and exploratory temporal dynamics. 用于炎症性肠病连续生物标志物监测的可穿戴式汗液生物传感器:可行性、一致性和探索性时间动态。
IF 7.9 1区 医学
Clinical and Translational Medicine Pub Date : 2026-11-01 DOI: 10.1002/ctm2.70896
Annapoorna Ramasubramanya, Kai-Chun Lin, Sarah Shahub, Alexandra R McDermott, Zachary D Fine, Robert P Hirten, Jessica Whang, Drew Helmus, Sriram Muthukumar, Bruce E Sands, David T Rubin, Shalini Prasad
{"title":"A wearable perspiration biosensor for continuous biomarker monitoring in inflammatory bowel disease: Feasibility, concordance, and exploratory temporal dynamics.","authors":"Annapoorna Ramasubramanya, Kai-Chun Lin, Sarah Shahub, Alexandra R McDermott, Zachary D Fine, Robert P Hirten, Jessica Whang, Drew Helmus, Sriram Muthukumar, Bruce E Sands, David T Rubin, Shalini Prasad","doi":"10.1002/ctm2.70896","DOIUrl":"https://doi.org/10.1002/ctm2.70896","url":null,"abstract":"<p><strong>Background: </strong>Serum C-reactive protein (CRP) and faecal calprotectin, used to monitor inflammatory bowel disease (IBD) between endoscopies, require intermittent blood or stool sampling. We assessed whether a skin-worn perspiration sensor could measure CRP and calprotectin continuously; TNFα and IL-6 were exploratory analytes.</p><p><strong>Methods: </strong>At three US centres, perspiration biomarkers were recorded continuously for 3-30 days in 52 IBD patients (27 ulcerative colitis, 24 Crohn's disease, 1 indeterminate colitis) and 19-32 days in 9 controls, with serum CRP and faecal calprotectin sampled at baseline and study end. Agreement was assessed using correlation and Bland-Altman analysis; ROC-derived cutoffs matched serum CRP 5 mg/L and faecal 250 µg/g. Circadian rhythmicity and ultradian (4-12 h) power were compared among biochemically active IBD (serum CRP > 5 mg/L; n = 15), inactive (n = 37), and controls.</p><p><strong>Results: </strong>47 of 52 IBD participants (90.4%) completed the protocol. Across 99 paired observations, perspiration CRP correlated with serum CRP (r = .52-.58); perspiration and faecal calprotectin correlated in ulcerative colitis (r = .59-.62) but not in Crohn's disease. A perspiration CRP cutoff of 1551 pg/mL (serum 5 mg/L) gave 85.7% sensitivity and 89.4% specificity; a calprotectin cutoff of 385 (µg/g)·min (faecal 250 µg/g) gave 92.3% and 67.9%. Negative predictive values were high (95%-97%), positive modest (57%). Circadian MESOR and amplitude of both markers were higher in active than inactive IBD. Ultradian power differed by group for calprotectin (Kruskal-Wallis p = .0005) and CRP (p = .0037)-highest in active disease, lowest in controls-but the active-inactive difference was non-significant after false-discovery-rate correction.</p><p><strong>Conclusions: </strong>Perspiration CRP agreed moderately with serum CRP, and perspiration calprotectin with faecal calprotectin in ulcerative colitis only. Their high negative predictive values support the study as a non-invasive adjunct to, not a substitute for, standard-of-care testing. All findings are preliminary, and the temporal-dynamics results are hypothesis-generating, needing confirmation in a larger, prospectively designed, endoscopy-anchored cohort.</p>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"16 11","pages":""},"PeriodicalIF":7.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书